Status:

COMPLETED

Rectal Reconstruction in Treating Patients Who Are Undergoing Surgery for Rectal Cancer

Lead Sponsor:

Swiss Cancer Institute

Conditions:

Colorectal Cancer

Eligibility:

All Genders

18+ years

Phase:

PHASE3

Brief Summary

RATIONALE: Rectal reconstruction after surgery to treat rectal cancer may help patients keep some of their bowel function. It is not yet known which method of rectal reconstruction is most effective a...

Detailed Description

This is a randomized, multicenter study. Patients are stratified according to participating center, gender, distance of the distal tumor margin from the dentate line (\> 5 cm vs ≤ 5 cm), age (\< 70 vs...

Eligibility Criteria

Inclusion

  • Histologically proven rectal adenocarcinoma or rectal adenoma with/without neoadjuvant radiochemotherapy
  • Total mesorectal excision needed
  • Age ≥ 18 years
  • Clinically normal function of the sphincter muscles (no history of frequent fecal incontinence for liquid or solid stools)
  • Any T, any N, any M or adenoma
  • An R0-resection is expected (liver metastases planned to be simultaneously
  • Written informed consent, signed and dated by the patient and the investigator
  • Completed baseline quality of life questionnaire
  • Exclusion criteria:
  • Rectal tumor other than adenocarcinoma or adenoma
  • Previous rectal cancer surgery, other than local excision within the last 2 months
  • Histologically proven chronic inflammatory bowel disease
  • Contraindications to any of the 3 surgical techniques
  • BMI \> 35
  • Patients with psychiatric, addictive or any disorder that would prohibit the understanding and giving of informed consent, completing the QL questionnaires and/or following the structured interview
  • Inability to read and understand any of the languages available on the QL questionnaires,and spoken during the interview (German, French, Italian)

Exclusion

    Key Trial Info

    Start Date :

    July 1 2005

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    August 1 2016

    Estimated Enrollment :

    336 Patients enrolled

    Trial Details

    Trial ID

    NCT00238381

    Start Date

    July 1 2005

    End Date

    August 1 2016

    Last Update

    May 15 2019

    Active Locations (18)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 5 (18 locations)

    1

    Kreiskrankenhaus Lörrach

    Loerrach, Germany, 79539

    2

    Kantonsspital Aarau

    Aarau, Switzerland, CH-5001

    3

    Zuger Kantonsspital AG

    Baar, Switzerland, 6340

    4

    Universitaetsspital-Basel

    Basel, Switzerland, CH-4031